• Home
  • About Journal
    Journal Introduction
    Editorial Board
    Youth Editorial Board
    Cooperating Institutions
    Editorial Department
  • Submission Guidelines
  • Policies & Statements
    Ethical Guidelines for Publication
    Academic Misconduct Statement
    Open Access (OA) Statement
    AIGC Use Statement
  • Journal Subscription
  • Download Center
  • 中文版
Cite this article:
WANG Xue,ZHAO Xiaoyu,ZHOU Zequan,XING Mengzhen,GAO Yunhua,ZHAO Lichun,ZHANG Suohui.Research progress of Tranexamic acid in treatment of melasma[J].Journal Of Pharmaceutical Research,2020,39(6):348-354[Click to copy]
【Print this page】      【Download PDF Full Text】   【View/Add Comment】  【Download reader】  【 Close 】
←Previous|Next→ Archive    Advanced Search
This article has been viewed: 3578times   Download 3295次 QR Code for this article
Scan with your phone!
氨甲环酸在治疗黄褐斑领域中的应用进展
王雪1,2,赵小峪2,周泽荃2,邢梦真2,高云华2,赵立春1,张锁慧2
Font:Larger+|Default|Smaller-
(1.广西中医药大学药学院,广西 南宁 530200;2.中国科学院理化技术研究所化学转换和功能材料重点实验室,北京 100190)
摘要:
黄褐斑是一种常发于面部的难治性皮肤疾病,以不规则的色素沉着斑为特征。目前主要治疗药物有对苯二酚、维A酸等,但其副作用较大。氨甲环酸是一种人工合成的赖氨酸衍生物,属于抗纤维蛋白溶解剂,经FDA批准用于治疗月经过多和预防出血。另外,氨甲环酸具有治疗黄褐斑功效,它通过对纤溶酶原激活途径的抑制作用,从而减轻色素沉着症状。本文在PubMed、Web of Science、CNKI、ScienceDirect等数据库进行了广泛的文献检索,对氨甲环酸在治疗黄褐斑领域的制剂学研究和临床有效性研究进行了资料归纳与分析,为临床上应用氨甲环酸治疗黄褐斑提供参考。
关键词:  氨甲环酸  黄褐斑  色素沉着
DOI:10.13506/j.cnki.jpr.2020.06.009
基金项目:
Research progress of Tranexamic acid in treatment of melasma
WANG Xue1,2,ZHAO Xiaoyu2,ZHOU Zequan2,XING Mengzhen2,GAO Yunhua2,ZHAO Lichun1,ZHANG Suohui2
(1.College of Pharmacy, Guangxi University of Chinese Medicine, China 530200;2.Key Laboratory of Photochemical Conversion and Optoelectronic Materials,Technical Institute of Physics and Chemistry,Chinese Academy of Sciences,China 100190)
Abstract:
Melasma is a common acquired pigmentary disorder marked by irregular hyperpigmented macules or patches. Traditional topical therapies including hydroquinone, tretinoin and so on. however , there are many side effects. Tranexamic acid is a plasmin inhibitor, a synthetic derivative of the amino acid lysine. It is approved by the US Food and Drug Administration for treatment of menorrhagia and to prevent hemorrhage.Tranexamic acid has consistently been reported as an effective treatment of melasma, it exerts its effect by inhibiting plasminogen activator. A literature search was performed using PubMed, Web of Science, CNKI, ScienceDirect database systematic reviews. We summarized and analyzed the pharmacological study and clinical study of tranexamic acid in the treatment of melasma, and we provide a reference for the clinical application of tranexamic acid in the treatment of melasma.
Key words:  Tranexamic acid  Melasma  Chloasma  Hyperpigmentation
Today's Visits:527    Total Visits:2383269
Website copyright:Editorial Board of Journal of Pharmaceutical Research     鲁ICP备17018036号-3     鲁公网安备 37010202001351号
Sponsored by:Shandong Institute for Food and Drug Control Shandong Pharmaceutical Association Address:No.2749 Xinluo Street,High-Tech Zone,Jinan,P.R.China Postcode:250101
Telephone Number:0531-81216586 Email :yaoxueyanjiu@163.com;yaoxueyanjiu@126.com
Technical Support:Beijing Qinyun Technology Co., Ltd.